Midgard Science
B

BioAgilytix

San Diego, CA, United States bioagilytix.com From their website, Nov 2026

  • GMP
  • CLIA

Work here? Claim this listing

About

BioAgilytix provides bioanalytical and CMC analytical services for drug development programs across preclinical, clinical, and commercial stages. It serves pharmaceutical and biotechnology clients with support for pharmacokinetics, immunogenicity, biomarkers, drug metabolism, assay development, sample analysis, kit production, diagnostic testing, and QC release and stability testing. The company operates globally with laboratories in the U.S., Europe, and Australia, plus partner labs in China.

Services

  • Pharmacokinetics (PK) services

    Develops and executes PK assays and strategies to support exposure, dose, and therapeutic performance assessments across preclinical and clinical studies.

  • Drug metabolism (DMPK) services

    Performs DMPK assays, custom drug metabolism research, and IND-enabling studies to assess drug-drug interaction potential, metabolic stability, metabolite profiling, and protein binding.

    ADME, DMPK & toxicology

  • Immunogenicity testing

    Assesses anti-drug antibodies, neutralizing antibodies, cellular immunogenicity, cytokine production, and other immune responses for therapeutic candidates.

  • ADA assay development

    Develops and validates anti-drug antibody assays to detect and characterize unwanted immunogenicity in biologic drug candidates.

  • Cytokine testing

    Measures cytokines, including multiplexed cytokine panels, to support immune system analysis and evaluation of drug safety and efficacy.

  • Biomarker testing

    Develops, validates, and runs biomarker assays to assess efficacy, safety, mechanism of action, target engagement, and toxicity.

  • Off-the-shelf assays

    Provides ready-to-use assays for regulated or nonregulated sample analysis to shorten timelines and reduce costs.

  • CMC bioassay services

    Develops and validates functional, binding, and cell-based potency assays for CMC analytical strategies through commercial release.

14 more services
  • CMC analytical development
  • CMC biophysical services
  • Method transfer
  • Assay creation
  • Sample analysis
  • Kit production
  • Diagnostic testing
  • QC release & stability testing
  • Pharmacokinetics
  • Immunogenicity
  • Drug Metabolism
  • Biomarkers
  • CMC Analytical & GMP Testing
  • Lab Automation Systems
What to send
  • Serum
  • Plasma
  • Urine
  • Saliva
  • CSF
  • Swabs
  • Tissue homogenates

Capabilities

Assays and studies
  • Immunogenicity
  • Bioanalysis
  • Antibodies
  • PK/PD
  • ADCs
  • Flow cytometry
18 more
  • Small molecules
  • Cell-based assays
  • Cell therapy
  • Stability studies
  • LBA/Immunoassays
  • Virology
  • Molecular assays
  • Mass spectrometry
  • ELISA
  • MSD
  • qPCR
  • ddPCR
  • LC/HRMS
  • SPR
  • Gyrolab
  • Biacore
  • Luminex
  • ImmunoCAP
Scale and capacity
  • 1100+ employees
  • 800+ assays developed annually
  • 5000000+ tests reported annually
  • 285,109 total sq. ft. Durham & Morrisville laboratories
  • 22,205 total sq. ft. Boston laboratory
  • 3,222 sq. meters Hamburg laboratory
14 more
  • 3000 sq. meters Melbourne laboratory
  • 34,000 total sq. ft. San Diego laboratory
  • 150 sq. meters Brisbane laboratory
  • 200 square meters Sydney laboratory
  • 30+ years experience
  • 1100+ employees & growing
  • Durham, North Carolina campus: 285,109 total sq. ft.
  • San Diego laboratory: 34,000 total sq. ft.
  • Boston laboratory: 22,205 total sq. ft.
  • Hamburg laboratory: 3,222 sq. meters
  • Brisbane laboratory: 150 sq. meters
  • Melbourne laboratory: 3000 sq. meters
  • Sydney laboratory: 200 square meters
  • GMP-compliant labs in Durham, North Carolina and Hamburg, Germany
Therapeutic areas
  • Cancer
  • Autoimmune diseases
  • Infectious diseases

Instruments and platforms

  • SpectraMax
  • BioTek
  • QX200
  • QuantStudio
  • Orbitrap Exploris 240
  • CytoFLEX
13 more
  • Sciex Triple Quad 7500
  • Sciex ZenoTOF 7600
  • Sciex ECHO MS+
  • Waters ACQUITY Premier UPLC
  • Thermo Scientific Orbitrap Exploris 240
  • Waters Xevo TQ-S
  • Biacore
  • Gyrolab
  • Luminex
  • Orbitrap Exploris
  • LC/MS
  • LC/HRMS
  • QTOF

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • Bispecific
  • ADC
  • Peptide
  • Cell therapy
3 more
  • Recombinant protein
  • Vaccine
  • Biosimilar
Species and models
  • Rodents
  • Non-human primates
  • Humans
  • Murine antibodies
  • Chimeric antibodies
  • Humanized antibodies
8 more
  • Fully human antibodies
  • Bacteria
  • Eukaryotic cells
  • Hepatocytes
  • Hepatic cytosol
  • Hepatic mitochondrial fraction
  • Hepatic S9 fraction
  • Recombinant bacteria

Certifications

As the company states them, with the certificate or registry record where there is one.

  • CLIASelf-reported

    Scope: diagnostic testing

  • CAPSelf-reported

    Scope: diagnostic testing

  • GMPSelf-reported

    Scope: CMC bioassay and QC testing

Company

Type
CRO
Team
1100+ employees

Locations

Office
1320 Soldiers Field Road Boston, MA 02135 United States
Sites
  • Durham, United States
  • Morrisville, United States
  • Boston, United States
  • Hamburg, Germany
  • Brisbane, Australia
  • Melbourne, Australia
  • Sydney, Australia
  • Beijing, China
Serves
Global, U.S., Europe, Australia, China
FDA GLP site
BioAgilytix Labs, Durham, US source

Public records

GLP
Inspected under GLP · FDA source
FDA drug establishment registration
3007929739 · ANALYSIS source
CMS CLIA laboratory
34D2030957 · DURHAM source

Similar labs